Richard Young
Fortune : 742 944 $ au 30/06/2026
Fortune : 742 944 $ au 30/06/2026
Richard A. Young was the founder of Dewpoint Therapeutics, Inc., founded in 2020, and Syros Pharmaceuticals, Inc., founded in 2011, where the title held was Independent Director from 2011 to 2024.
Dr. Young is also the founder of CAMP4 Therapeutics Corp., founded in 2016, holding the title of Independent Director since 2016.
Current jobs include Director at Precede Biosciences, Inc. since 2023, Director at Paratus Sciences Corp.
since 2021, Professor-Biology at Massachusetts Institute of Technology since 1984, and Member at Whitehead Institute for Biomedical Research since 1984.
Former jobs include Independent Director at Enzon Pharmaceuticals, Inc. from 2011 to 2013, Independent Director at Omega Therapeutics, Inc. from 2017 to 2024, and Senior Vice President-Steel Mill Product Sales at Eastern Alloys, Inc. Education includes undergraduate studies at Indiana University and a doctorate from Yale University conferred in 1975.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/06/2026 | 170 010 ( 0,36 % ) | 742 944 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CAMP4 THERAPEUTICS CORPORATION | Fondateur | 01/01/2016 |
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Provides research and technology services | Corporate Officer/Principal | 01/01/1984 |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Corporate Officer/Principal | 01/01/1984 |
Dewpoint Therapeutics, Inc.
Dewpoint Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biomolecular condensates biotechnology company | Fondateur | 01/10/2020 |
Paratus Sciences Corp.
Paratus Sciences Corp. BiotechnologyHealth Technology Operates as a biotechnology company | Directeur/Membre du Conseil | 01/11/2021 |
Precede Biosciences, Inc.
Precede Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Offers liquid biopsy platform for drug development | Directeur/Membre du Conseil | 01/02/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
| OMEA THER | Directeur/Membre du Conseil | 06/12/2024 |
| SYROS PHARMACEUTICALS, INC. | Fondateur | 15/11/2024 |
Enzon Pharmaceuticals, Inc.
Enzon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative therapeutics for cancer patients | Directeur/Membre du Conseil | 20/11/2013 |
| ░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 12 |
|---|---|
Enzon Pharmaceuticals, Inc.
Enzon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative therapeutics for cancer patients | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Indiana University
Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eastern Alloys, Inc.
Eastern Alloys, Inc. Other Metals/MineralsNon-Energy Minerals Manufactures and recycles zinc alloys and products | Non-Energy Minerals |
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Provides research and technology services | Commercial Services |
Syros Pharmaceuticals, Inc.
Syros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which developing care for the frontline treatment of patients with hematologic malignancies | Health Technology |
Camp4 Therapeutics Corp.
Camp4 Therapeutics Corp. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in the development of regulatory RNA-based therapeutics | Health Technology |
Omega Therapeutics, Inc.
Omega Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for general and rare genetic diseases, immunology, inflammation, oncology and metabolic diseases | Health Technology |
Dewpoint Therapeutics, Inc.
Dewpoint Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biomolecular condensates biotechnology company | Health Technology |
Paratus Sciences Corp.
Paratus Sciences Corp. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Precede Biosciences, Inc.
Precede Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Offers liquid biopsy platform for drug development | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national